Dharmaj Crop Guard Ltd
Incorporated in 2015, Dharmaj Crop Guard manufactures and deals in pesticides including concessionaires of public health products for pest control, insecticides, herbicide, fertilizers and allied products related to research and technical formulations[1]
- Market Cap ₹ 817 Cr.
- Current Price ₹ 242
- High / Low ₹ 391 / 165
- Stock P/E 16.8
- Book Value ₹ 131
- Dividend Yield 0.00 %
- ROCE 12.0 %
- ROE 9.28 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 11.6% over last 3 years.
- Debtor days have increased from 70.7 to 95.3 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 136 | 193 | 298 | 388 | 524 | 654 | 951 | 1,099 | |
| 126 | 175 | 267 | 344 | 483 | 591 | 876 | 1,003 | |
| Operating Profit | 10 | 18 | 31 | 44 | 41 | 63 | 75 | 96 |
| OPM % | 8% | 9% | 10% | 11% | 8% | 10% | 8% | 9% |
| 1 | 1 | 1 | 2 | 4 | 3 | 2 | 2 | |
| Interest | 2 | 2 | 1 | 3 | 2 | 3 | 13 | 15 |
| Depreciation | 2 | 2 | 3 | 5 | 5 | 5 | 18 | 19 |
| Profit before tax | 7 | 14 | 28 | 39 | 38 | 57 | 46 | 65 |
| Tax % | 28% | 26% | 26% | 26% | 30% | 23% | 24% | |
| 5 | 11 | 21 | 29 | 27 | 44 | 35 | 49 | |
| EPS in Rs | 25.10 | 6.54 | 12.74 | 11.62 | 7.95 | 13.13 | 10.31 | 14.40 |
| Dividend Payout % | 0% | 0% | 0% | 1% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 35% |
| TTM: | 36% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 7% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -13% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 12% |
| Last Year: | 9% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 16 | 16 | 25 | 34 | 34 | 34 | 34 |
| Reserves | 9 | 19 | 40 | 60 | 281 | 326 | 361 | 411 |
| 20 | 20 | 27 | 37 | 52 | 112 | 116 | 139 | |
| 17 | 37 | 46 | 98 | 65 | 92 | 223 | 373 | |
| Total Liabilities | 48 | 93 | 129 | 220 | 432 | 563 | 733 | 956 |
| 12 | 22 | 39 | 40 | 40 | 312 | 311 | 321 | |
| CWIP | 0 | 2 | 1 | 18 | 90 | 2 | 7 | 2 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 36 | 68 | 89 | 161 | 302 | 249 | 416 | 632 | |
| Total Assets | 48 | 93 | 129 | 220 | 432 | 563 | 733 | 956 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 3 | 2 | 13 | 16 | -24 | 7 | 39 | |
| -4 | -15 | -18 | -24 | -191 | -62 | -33 | |
| 0 | 12 | 6 | 7 | 214 | 57 | -9 | |
| Net Cash Flow | -0 | -1 | 1 | 0 | -1 | 3 | -3 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 46 | 63 | 44 | 81 | 51 | 66 | 95 |
| Inventory Days | 52 | 67 | 68 | 74 | 62 | 66 | 68 |
| Days Payable | 44 | 80 | 61 | 108 | 31 | 47 | 96 |
| Cash Conversion Cycle | 54 | 49 | 51 | 47 | 81 | 84 | 67 |
| Working Capital Days | 36 | 20 | 33 | 43 | 56 | 65 | 53 |
| ROCE % | 39% | 42% | 40% | 17% | 15% | 12% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16h - Q2: Revenue ₹3,473m, EBITDA ₹318m, PAT ₹174m; H1: Revenue ₹7,146m, EBITDA ₹825m, PAT ₹499m, Nov 13, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
16h - Investor Presentation for the Second Quarter and Half year ended September 30,2025
-
Result-Financial Result For The Second Quarter And Half Year Ended September 30,2025
18h - Approved Q2 and H1 unaudited results (Sep 30, 2025): H1 profit ₹499.23m, revenue ₹7,146.46m
-
Board Meeting Outcome for Outcome Of The Board Meeting -November 13,2025
18h - Board approved Q2/H1 results (Sep 30, 2025): H1 revenue ₹7,146.46m; H1 profit ₹499.23m.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
7 Nov - Interactions with investors / analysts are scheduled to take place, we hereby enclose the requisite details of the Post Earnings Call.
Annual reports
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025TranscriptNotesPPT
-
Jun 2025Transcript PPT REC
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT REC
-
Apr 2024TranscriptNotesPPTREC
-
Feb 2024TranscriptNotesPPT
-
Nov 2023TranscriptPPT
-
Nov 2023Transcript PPT REC
-
Jul 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
Business Overview:[1][2]
Company is in the business of agrochemical formulations & active ingredients and have the following business segments
a) Branded Formulations (B2C)
b) Institutional Formulations (B2B)
c) Active Ingredients (B2B)
Company manufactures pesticides, weedicides, fungicides, herbicides and has an active portfolio of 190+ products, catering
to a wide customer base including bulk consumers, retailers and export customers